Professor Chen is a full Professor and attending physician of Chang Gung University and Chang Gung Memorial Hospital, Taiwan. He was trained in sleep medicine at Stanford Sleep Disorders Clinic and the Division of sleep medicine, Center for Sleep and Respiratory Neurobiology-CSRN in Philadelphia.
Dr. Chen was the founder of Sleep Center in Chang Gung Memorial Hospital. He has served as the 3rd President of Taiwan Society of Sleep Medicine, Secretary General of World Sleep Federation, Vice President of Asian Sleep Research Society, President of Asian Society of Sleep Medicine and now the head of the Assembly of Neurobiology and Sleep of APSR.
Dr. Chen published more than 180 SCI articles, two books, and owns several patents about sleep. He won the Fukuchi Award of APSR in 2018 and was named as world’s top 2% Scientists jointly published by Elsevier BV and Stanford University in 2020 and 2021.
Dr. Kang-Yun Lee is Professor of Internal medicine and Vice President of Taipei Medical University (TMU). He also heads the Asthma Assembly of Asian Pacific Society of Respirology. Dr. Lee qualified his first degree of Medicine at TMU and received a PhD in clinical pharmacology at imperial College London in 2006.
Dr. Lee had been working on pathogenesis of asthma, COPD, and lung cancer. In addition to clinically orientated research, he has been working on molecular control of inflammation and immunity in lung diseases. He is interested in microenvironment and immune therapy for lung cancer. His lab identified a novel myeloid-derived suppressor cell (MDSC) in lung cancer, which has been implicated in tumor aggressiveness and drug resistance. Dr. Lee also participates in a great number of clinical trials, in variable lung diseases, including airways diseases, lung cancer and pneumonia.
Dr. Rebecca Chou-Jui Lin is a pulmonologist at Taoyuan General Hospital, Ministry of Health and Welfare, Taiwan. She specializes in tuberculosis (TB) treatment, serves as regional TB consultant, and is one of the board of directors of Taiwan Society of Tuberculosis and Lung Diseases. She has been leading one of the five Taiwan Multidrug-resistant Tuberculosis Consortium (TMTC) teams since 2007, and actively involved in introducing shorter regimens and active drug safety monitoring system for multidrug-resistant TB in Taiwan. She also participated in providing technical assistance regarding uptake of shorter regimen of drug-resistant TB in the Philippines and facilitated in several online international training courses of clinical management of drug-resistant TB over the past few years.
Dr. Hao-Chien Wang is professor of Internal medicine in College of Medicine National Taiwan University and consultant physician in Chest specialty practicing at National Taiwan University Hospital in Taipei city. Now he is the chairman of Taiwan Society of Pulmonary & Critical Medicine since 2020. He also is the deputy head of COPD assembly of APSR.
Dr. Wang has an outstanding career marked by contributions to academic research, education, training and clinical practice. Dr. Wang’s research focuses mainly on basic and clinical researches on obstructive airway diseases, acute lung injury and chest ultrasonography in diagnosing of pulmonary diseases,. He has published more than 100 papers in national and international peer reviewed journals. Furthermore, Dr. Wang is an investigator for several ongoing global clinical studies in the area of respiratory disease including pneumonia, COPD & asthma.
Pan-Chyr Yang, MD, PhD National Taiwan University College of Medicine and National Taiwan University Hospital, Institute of Biomedical Sciences, Genomics Research Center, Academia Sinica, Taiwan.
Dr. Yang is Chair Professor of National Taiwan University. He is former president of National Taiwan University and member of Academia Sinica, World Academic of Science and the National Academy of Inventors. His research interests are lung cancer genomics and precision cancer therapy. He is actively involved in developing novel strategies, including multi-omics, aptamer, nanotechnology and siRNA to improve diagnosis and therapy for cancer and infectious diseases, including COVID-19. His team recently by proteogenomics revealed distinct genetic and environmental signatures of lung cancer pathogenesis and progression in never-smokers. He received the 2020 IASLC Joseph W. Cullen Distinguished Award because of the contributions in leading the lung cancer screening and improving the survival of lung cancer patients.